In a growing number of people who contract COVID-19, symptoms persist long after the initial SARS-CoV-2 infection subsides. COVID-19 and long COVID patients display a variety of symptoms that reveal SARS-CoV-2’s versatility and its long-lasting impact on organ function. While this heterogeneity makes it difficult to study the disease, scientists apply every available technology to investigate the virus’ pathological mechanisms.

In this webinar, Dr. Floyd Chilton, Director of the Precision Nutrition and Wellness Initiative at the University of Arizona, and Dr. Thomas Bumol, Executive Vice President and Director of the Allen Institute for Immunology, will discuss how they combine metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2’s ability to attack multiple organs, even after the virus has been cleared from the body.

Hosted by The Scientist.